NO904901L - N-substituerte derivater av 3r,4r-etyl-((1-metyl-1h-imidazol-5-yl)metyl) -2-pyrrolidinon. - Google Patents

N-substituerte derivater av 3r,4r-etyl-((1-metyl-1h-imidazol-5-yl)metyl) -2-pyrrolidinon.

Info

Publication number
NO904901L
NO904901L NO90904901A NO904901A NO904901L NO 904901 L NO904901 L NO 904901L NO 90904901 A NO90904901 A NO 90904901A NO 904901 A NO904901 A NO 904901A NO 904901 L NO904901 L NO 904901L
Authority
NO
Norway
Prior art keywords
methyl
pyrrolidinon
imidazol
ethyl
substituted derivatives
Prior art date
Application number
NO90904901A
Other languages
English (en)
Other versions
NO177056B (no
NO177056C (no
NO904901D0 (no
Inventor
Pamela Albaugh
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of NO904901D0 publication Critical patent/NO904901D0/no
Publication of NO904901L publication Critical patent/NO904901L/no
Publication of NO177056B publication Critical patent/NO177056B/no
Publication of NO177056C publication Critical patent/NO177056C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
NO904901A 1989-11-13 1990-11-12 Analogifremgangsmåte ved fremstilling av N-substituerte derivater av 3R,4R-etyl-[(1-metyl-1H-imidazol-5-yl)metylÅ-2-pyrrolidinon NO177056C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/434,929 US5264449A (en) 1989-11-13 1989-11-13 N-substituted derivatives of 3R,4R-ethyl-[(1-methyl-1H-imidazol-5-yl)methyl]-2-pyrrolidinone

Publications (4)

Publication Number Publication Date
NO904901D0 NO904901D0 (no) 1990-11-12
NO904901L true NO904901L (no) 1991-05-14
NO177056B NO177056B (no) 1995-04-03
NO177056C NO177056C (no) 1995-07-12

Family

ID=23726283

Family Applications (1)

Application Number Title Priority Date Filing Date
NO904901A NO177056C (no) 1989-11-13 1990-11-12 Analogifremgangsmåte ved fremstilling av N-substituerte derivater av 3R,4R-etyl-[(1-metyl-1H-imidazol-5-yl)metylÅ-2-pyrrolidinon

Country Status (15)

Country Link
US (1) US5264449A (no)
EP (1) EP0429232A1 (no)
JP (1) JPH03188075A (no)
CN (1) CN1026589C (no)
AU (1) AU631025B2 (no)
CA (1) CA2027604A1 (no)
FI (1) FI905589A0 (no)
HU (1) HU207512B (no)
IE (1) IE904067A1 (no)
IL (1) IL96088A (no)
NO (1) NO177056C (no)
NZ (1) NZ235735A (no)
PT (1) PT95874A (no)
RU (1) RU2015978C1 (no)
ZA (1) ZA908386B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453434A (en) * 1989-11-13 1995-09-26 Allergan, Inc. N-substituted derivatives of 3R,4R-ethyl-[(1-methyl-1H-imidazol-5-yl)methyl]-2-pyrrolidone
EP0618913B1 (en) * 1991-12-18 1996-08-14 Schering Corporation Imidazolyl or imidazoylalkyl substituted with a four or five membered nitrogen containing heterocyclic ring
CA2125060C (en) * 1993-07-02 1999-03-30 Henry P. Dabrowski Ophthalmic solution for artificial tears
US5895645A (en) * 1995-01-31 1999-04-20 Bausch & Lomb Incorporated Opthalmic solution for artificial tears
US5677327A (en) * 1995-06-22 1997-10-14 Allergan Method for identifying muscarinic agents lacking miotic side effects
AU717298B2 (en) * 1996-04-03 2000-03-23 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US6001835A (en) * 1996-04-03 1999-12-14 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
EP0891360A4 (en) * 1996-04-03 2002-05-15 Merck & Co Inc FARNESYL PROTEIN TRANSFERASE INHIBITORS
US5675019A (en) * 1996-07-18 1997-10-07 Allergan Process for making piloloctam and derivatives thereof
US5675038A (en) * 1996-07-18 1997-10-07 Allergan Lithium and amine dissolving metal reduction
US5800807A (en) * 1997-01-29 1998-09-01 Bausch & Lomb Incorporated Ophthalmic compositions including glycerin and propylene glycol
US7232924B2 (en) 2001-06-11 2007-06-19 Xenoport, Inc. Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7132444B2 (en) * 2002-01-07 2006-11-07 Sun Pharmaceutical Industries, Ltd. Process for the preparation of trans-3-ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(4-methyl cyclohexyl) amino]carbonyl]amino]sulfonyl] phenyl]ethyl]-2-oxo-1H-pyrrole-1-carboxamide
CN104211638A (zh) * 2014-08-13 2014-12-17 李增 一种脂肪氨基取代的芸香碱类衍生物及其制备和作为抗阿尔兹海默症的药物中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470197A (en) * 1967-08-30 1969-09-30 Miles Lab 1-substituted derivatives of 3-ethyl-4 - (1-methylimidazolyl-(5)-methyl)-2-pyrrolidinone
US5055467A (en) * 1989-11-13 1991-10-08 Allergan, Inc. Pharmaceutical epinephrine-pilocarpine compounds

Also Published As

Publication number Publication date
EP0429232A1 (en) 1991-05-29
NO177056B (no) 1995-04-03
HUT56360A (en) 1991-08-28
FI905589A0 (fi) 1990-11-12
NO177056C (no) 1995-07-12
CN1051730A (zh) 1991-05-29
NZ235735A (en) 1992-03-26
PT95874A (pt) 1991-09-13
ZA908386B (en) 1991-08-28
NO904901D0 (no) 1990-11-12
US5264449A (en) 1993-11-23
CA2027604A1 (en) 1991-05-14
AU6652890A (en) 1991-05-16
RU2015978C1 (ru) 1994-07-15
JPH03188075A (ja) 1991-08-16
IL96088A0 (en) 1991-07-18
CN1026589C (zh) 1994-11-16
AU631025B2 (en) 1992-11-12
HU207512B (en) 1993-04-28
HU907116D0 (en) 1991-05-28
IE904067A1 (en) 1991-05-22
IL96088A (en) 1995-03-30

Similar Documents

Publication Publication Date Title
NO904901L (no) N-substituerte derivater av 3r,4r-etyl-((1-metyl-1h-imidazol-5-yl)metyl) -2-pyrrolidinon.
NO306783B1 (no) Fremgangsmåte for fremstilling av 1-(2'-deoksy-2',2'-difluor-D-ribofuranosyl-4-aminopyrimidin-2-on)hydroklorid
NO973479L (no) Substituerte heterosykliske forbindelser, fremgangsmåte for fremstilling og farmasöytiske blandinger inneholdende samme
PT1000048E (pt) Derivados substituidos do 1,2,3,4-tetrahidronaftaleno
DE3779563D1 (de) Reduzierte derivate von avermectin.
NO20004809L (no) Trisubstituerte 1,3,5-triazinderivater for behandling av HIV- infeksjoner
DE68913022D1 (de) Heterozyklische Derivate.
NO892083D0 (no) Fremgangsmaate for fremstilling av arylmetylenyl-derivaterav tiazolidinoner, imidazolidinoner og oksazolidinoner.
MX20359A (es) Derivados de 2-oxindol 3-substituidos.
DK0992510T3 (da) N6-heterocyklisk substituerede adenosinderivater
NO20002443L (no) FremgangsmÕte for fremstilling av derivater av taxoidklassen
EE9800227A (et) 17ß-karboksü-, karbotio- ja amiidandrostaanide laktoonderivaadid
DE58904761D1 (de) Chirale derivate des 1,2 -difluorbenzols.
IT8919316A0 (it) Benzoderivati di composti eterociclici contenenti azoto.
PT921125E (pt) Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
DK337583A (da) Herbicidt virksomme 5-oxo-2,3,6,7-tetrahydro-5h-thiazol(3,2-alfa)pyrimidinderivater samt fremgangsmaade til fremstilling deraf
FI932868A (fi) 2'-deoxi-2'2'-difluor(2,6,8-substituerade) purinnukleosider med virus-och cancerhaemmande aktivitet, samt mellanprodukter
BR9915027B1 (pt) derivados de 1,3-diaril-2-piridin-2-il-3-(3-piridin-2-ilamino)-propanol susbtituìdos, medicamento contendo tais compostos, processo de preparação do mesmo, e aplicação dos mesmos.
NO875495L (no) 1-acyl-2,3-dihydro-4(1h)-kinolinon-4-oksimderivater.
NO881135D0 (no) Fremgangsmaate for fremstilling av 1-(3-azido-2,3-dideoksy-betad-erytro-pentofuranosyl)-5-metyl-2(1h)-pyrimidinon.
EE03873B1 (et) Meetod alküüloksüfuranooni amiinderivaatide valmistamiseks, sel meetodil saadud ühendid ja nende kasutamine
ATE220674T1 (de) 12h-dibenzo(d,g)(1,3)dioxocin derivate
DE69019610D1 (de) Cyclische Derivate des Amidinylthiocarbapenems.
NO962809D0 (no) Fremgangsmåte for fremstilling av N-substituerte 4-ketoprolinderivater
MX9203486A (es) (quinolin-2-imetoxi)indol como inhibidores de la biosintesis de leucotrienos).